William Blair Boosts Earnings Estimates for Cooper Companies

The Cooper Companies, Inc. (NASDAQ:COO - Free Report) - Equities research analysts at William Blair raised their Q4 2025 earnings per share estimates for shares of Cooper Companies in a research note issued to investors on Monday, December 9th. William Blair analyst M. Andrew now expects that the medical device company will post earnings per share of $1.08 for the quarter, up from their prior estimate of $1.07. The consensus estimate for Cooper Companies' current full-year earnings is $3.98 per share.

A number of other research analysts have also issued reports on COO. Citigroup lowered their target price on Cooper Companies from $116.00 to $115.00 and set a "buy" rating on the stock in a report on Friday, December 6th. Needham & Company LLC reiterated a "hold" rating on shares of Cooper Companies in a report on Friday, December 6th. Morgan Stanley reduced their price target on Cooper Companies from $104.00 to $102.00 and set an "equal weight" rating for the company in a report on Friday, December 6th. Stifel Nicolaus reissued a "buy" rating and issued a $115.00 price objective (up from $110.00) on shares of Cooper Companies in a research note on Thursday, August 29th. Finally, Wells Fargo & Company lifted their price objective on Cooper Companies from $115.00 to $118.00 and gave the stock an "overweight" rating in a research note on Friday, December 6th. Four research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company's stock. According to MarketBeat, Cooper Companies currently has a consensus rating of "Moderate Buy" and a consensus target price of $117.00.

Cooper Companies Stock Performance

Shares of COO traded up $0.20 during mid-day trading on Wednesday, reaching $99.28. 1,171,722 shares of the company's stock traded hands, compared to its average volume of 1,156,494. Cooper Companies has a 12 month low of $84.26 and a 12 month high of $112.38. The stock has a market capitalization of $19.77 billion, a P/E ratio of 50.81, a price-to-earnings-growth ratio of 2.17 and a beta of 0.97. The business's 50-day moving average price is $104.09 and its 200-day moving average price is $98.88. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91.

Cooper Companies (NASDAQ:COO - Get Free Report) last released its quarterly earnings results on Thursday, December 5th. The medical device company reported $1.04 EPS for the quarter, topping the consensus estimate of $1.00 by $0.04. The business had revenue of $1.02 billion for the quarter, compared to analysts' expectations of $1.03 billion. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The company's revenue was up 9.8% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.87 earnings per share.

Insider Activity at Cooper Companies

In other Cooper Companies news, CEO Albert G. White III sold 114,992 shares of the company's stock in a transaction that occurred on Thursday, September 19th. The stock was sold at an average price of $110.53, for a total transaction of $12,710,065.76. Following the completion of the transaction, the chief executive officer now owns 165,273 shares of the company's stock, valued at $18,267,624.69. This represents a 41.03 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 2.00% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of the stock. LRI Investments LLC grew its stake in Cooper Companies by 4.5% in the 2nd quarter. LRI Investments LLC now owns 2,595 shares of the medical device company's stock valued at $227,000 after buying an additional 112 shares during the last quarter. Mitchell & Pahl Private Wealth LLC grew its holdings in shares of Cooper Companies by 1.5% during the 3rd quarter. Mitchell & Pahl Private Wealth LLC now owns 7,986 shares of the medical device company's stock valued at $881,000 after purchasing an additional 117 shares during the last quarter. Commonwealth Equity Services LLC increased its holdings in Cooper Companies by 0.8% in the 2nd quarter. Commonwealth Equity Services LLC now owns 15,600 shares of the medical device company's stock worth $1,362,000 after purchasing an additional 118 shares in the last quarter. Bleakley Financial Group LLC raised its stake in shares of Cooper Companies by 2.1% during the third quarter. Bleakley Financial Group LLC now owns 5,767 shares of the medical device company's stock valued at $636,000 after acquiring an additional 119 shares during the last quarter. Finally, First Horizon Advisors Inc. grew its position in shares of Cooper Companies by 4.8% in the 2nd quarter. First Horizon Advisors Inc. now owns 2,709 shares of the medical device company's stock valued at $236,000 after buying an additional 125 shares during the last quarter. 24.39% of the stock is currently owned by institutional investors.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.